Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yannick van Sleen

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
Frontiers in Immunology|July 3, 2023
Biomarkers in the era of targeted therapy in giant cell arteritis and polymyalgia rheumatica: is it possible to replace acute-phase reactants?Guillermo Carvajal Alegria, Mathilde Nicolas, Yannick van Sleen
RMD Open|February 12, 2022
Need and value of targeted immunosuppressive therapy in giant cell arteritisMaria Sandovici, Niels van der Geest, Yannick van Sleen, et al.
Iscience|January 22, 2026
Activation phenotypes defined by the coordinated expression of activation markers discriminate TCR-mediated and bystander T cell responsesTamara J C Schenk, Martijn Vos, Yannick van Sleen, et al.
Npj Aging|March 4, 2024
Effects of ageing and frailty on circulating monocyte and dendritic cell subsetsRosanne D Reitsema, Ashok K Kumawat, Bernd-Cornèl Hesselink, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 22, 2025
IL-2 mediates human bystander CD8+ T-cell responses to innate immune signalsTamara Johanna Cornelia Schenk, Martijn Vos, Yannick van Sleen, et al.
Journal of Autoimmunity|April 23, 2024
Impaired IL-6-induced JAK-STAT signaling in CD4<sup>+</sup> T cells associates with longer treatment duration in giant cell arteritisIdil Esen, Maria Sandovici, Peter Heeringa, et al.
Joint Bone Spine|July 11, 2020
Aortic involvement in giant cell arteritisGuillermo Carvajal Alegria, Yannick van Sleen, Jacoba Carolien Graver, et al.
Nature Reviews. Rheumatology|July 12, 2023
Effect of DMARDs on the immunogenicity of vaccinesYannick van Sleen, Kornelis S M van der Geest, Anke L W Huckriede, et al.
Arthritis Care & Research|June 18, 2023
Humoral SARS-CoV-2 Vaccine Responses in Patients With Giant Cell Arteritis and Polymyalgia Rheumatica: Decay After Primary Vaccination and Effects of the BoosterYannick van Sleen, Kornelis S M van der Geest, Anne-Marie Buisman, et al.
Rheumatology (Oxford, England)|July 12, 2019
High angiopoietin-2 levels associate with arterial inflammation and long-term glucocorticoid requirement in polymyalgia rheumaticaYannick van Sleen, Annemieke M H Boots, Wayel H Abdulahad, et al.
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Frontiers in Immunology|July 3, 2023
Biomarkers in the era of targeted therapy in giant cell arteritis and polymyalgia rheumatica: is it possible to replace acute-phase reactants?Guillermo Carvajal Alegria, Mathilde Nicolas, Yannick van Sleen
RMD Open|February 12, 2022
Need and value of targeted immunosuppressive therapy in giant cell arteritisMaria Sandovici, Niels van der Geest, Yannick van Sleen, et al.
Iscience|January 22, 2026
Activation phenotypes defined by the coordinated expression of activation markers discriminate TCR-mediated and bystander T cell responsesTamara J C Schenk, Martijn Vos, Yannick van Sleen, et al.
Npj Aging|March 4, 2024
Effects of ageing and frailty on circulating monocyte and dendritic cell subsetsRosanne D Reitsema, Ashok K Kumawat, Bernd-Cornèl Hesselink, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 22, 2025
IL-2 mediates human bystander CD8+ T-cell responses to innate immune signalsTamara Johanna Cornelia Schenk, Martijn Vos, Yannick van Sleen, et al.
Journal of Autoimmunity|April 23, 2024
Impaired IL-6-induced JAK-STAT signaling in CD4<sup>+</sup> T cells associates with longer treatment duration in giant cell arteritisIdil Esen, Maria Sandovici, Peter Heeringa, et al.
Joint Bone Spine|July 11, 2020
Aortic involvement in giant cell arteritisGuillermo Carvajal Alegria, Yannick van Sleen, Jacoba Carolien Graver, et al.
Nature Reviews. Rheumatology|July 12, 2023
Effect of DMARDs on the immunogenicity of vaccinesYannick van Sleen, Kornelis S M van der Geest, Anke L W Huckriede, et al.
Arthritis Care & Research|June 18, 2023
Humoral SARS-CoV-2 Vaccine Responses in Patients With Giant Cell Arteritis and Polymyalgia Rheumatica: Decay After Primary Vaccination and Effects of the BoosterYannick van Sleen, Kornelis S M van der Geest, Anne-Marie Buisman, et al.
Rheumatology (Oxford, England)|July 12, 2019
High angiopoietin-2 levels associate with arterial inflammation and long-term glucocorticoid requirement in polymyalgia rheumaticaYannick van Sleen, Annemieke M H Boots, Wayel H Abdulahad, et al.
Pageof 5